Company Overview and News

 
JLL / Jones Lang LaSalle Inc. 8-K (Current Report)

2018-09-19 sec.gov
United States<
JLL

 
 
CORRECTED (OFFICIAL)-Jones Lang LaSalle names Americas CEO of hotels, hospitality group

2018-09-13 reuters
(Reuters) - Jones Lang LaSalle Inc, a leading worldwide real estate firm, said on Thursday it has appointed a new chief executive officer for its Americas hotels group at a time investment in the industry is highly global and the investor base is changing.
JLL

 
Jones Lang LaSalle names Americas CEO of hotels, hospitality group

2018-09-13 reuters
Sept 13 (Reuters) - Jones Lang LaSalle Inc, a leading worldwide real estate firm, said on Thursday it has appointed a new chief executive officer for its Americas hotels group at a time when investment in the industry is highly global and the investor base is changing.
JLL

 
Impact of imposition of VAT on condominium sales: JLL report

2018-09-10 lankabusinessonline
Sept 10, 2018 (LBO) – In the wake of continuing uncertainty with regard to the effective date on the reintroduction of Value Added Tax (VAT) on residential condominiums, real-estate consulting agency, Jones Lang LaSalle (JLL) released a new report analyzing the likely impact of impending policy changes on the Sri Lankan real estate sector.
JLL

 
Jones Lang LaSalle (JLL) Down 3.9% Since Last Earnings Report: Can It Rebound?

2018-09-07 zacks
A month has gone by since the last earnings report for Jones Lang LaSalle (JLL - Free Report) . Shares have lost about 3.9% in that time frame, underperforming the S&P 500.
ALLY TGI KORS JLL

89
Tracking Al Gore's Generation Investment Management Portfolio - Q2 2018 Update

2018-09-04 seekingalpha - 1
The top three positions are Henry Schein, Dentsply Sirona, and Cooper Companies and they add up to ~23% of the entire portfolio.
JD BAP TXN TMO ADP GOOG CRM AYI.WI COO NKE AMZN IR CERN MELI AYI WSBF WSCC MA INFY MCHP HSIC CMG MULE V XRAY ADPVV GOOGL ADI INFY JLL WAT MSFT APTV

4
Co-working surge in HK sees a landmark leasing deal

2018-08-31 thestar.com.my
HONG KONG: One of Hong Kong’s biggest co-working leasing deals has added to an explosion in the number and size of such agreements.
CIG JLL CIGI

 
The Ratings Game: Cushman & Wakefield’s stock boosted as at least 5 analysts rate it a buy

2018-08-27 marketwatch
Shares of real estate services firm Cushman & Wakefield jumped Monday as analysts started coverage of the stock in a series of bullish notes.
CBG JLL CBRE

9
Alexandria Inks First Lease for 1818 Fairview Development

2018-08-23 zacks
Alexandria Real Estate Equities Inc. (ARE - Free Report) has bagged its first tenant at the 1818 Fairview development project — a four-story life-science office building located in the Lake Union submarket — per an article citing Jesse Ottele, Newmark Knight Frank’s real estate broker.
SOJA ARE SO STZ.B STZ PSB JLL WPC BLUE

 
JD.com-backed China Logistics Property eyes co-investments to expand, cut expenses

2018-08-23 theedgemarkets
HONG KONG (Aug 23): China Logistics Property Holdings (CNLP), backed by e-commerce giant JD.com Inc, plans to set up funds with industry players to co-invest in warehousing projects in a bid to ease capital pressure and double its domestic market share.
JLL

18
7 Athletes Turned Professional Investors

2018-08-22 investorplace
Growing up, Roger Staubach was the first athlete turned investor I can remember. Staubach, a Hall of Fame quarterback who played for the Dallas Cowboys, had a good head for business.
NKE GOOGL AAPL SBUX JLL GOOG

6
Google planning yet another office tower in Amazon’s backyard

2018-08-15 malaymail
SEATTLE, Aug 15 — Google is taking another big step onto Amazon.com Inc’s turf in Seattle’s fast-growing tech hub.
FB GOOGL JLL MSFT GOOG

 
Cannabis ‘Gold Rush’ will boost retail in Canada, RioCan says

2018-08-09 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
RIOCF JLL

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

CUSIP: 48020Q107